Menopause and Its Implications for Stroke in Women
- 24 June 2026
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (8) , 2531-2541
Abstract
Stroke is the third leading cause of death in women and a major driver of disability. Menopause is a universal transition for midlife women, which is accompanied by menstrual cycle changes, hormonal fluctuations, and, for many women, the occurrence of menopausal symptoms. An accumulating body of research underscores the importance of menopause and its features to stroke risk in women, including the type and timing of menopause, endogenous hormone profiles, and menopausal symptoms, including vasomotor symptoms and sleep problems. In addition, menopausal hormone therapy, a leading approach to managing menopausal symptoms, has implications for stroke risk, which varies depending on the menopausal hormone therapy formulation, route of delivery, and the age and health of the recipient, with transdermal menopausal hormone therapy formulations administered to younger midlife women showing a more favorable profile. This review summarizes the data linking menopause and stroke, and offers suggestions to inform clinical decision-making. Knowledge gaps and directions for future research are highlighted.Keywords
This publication has 104 references indexed in Scilit:
- Elinzanetant for the Treatment of Vasomotor Symptoms Associated With MenopauseJAMA Internal Medicine, 2025
- The Women’s Health Initiative Randomized Trials and Clinical PracticeJAMA, 2024
- Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized TrialsJAMA, 2013
- Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior HysterectomyJAMA, 2011
- Menopause and the Metabolic SyndromeThe Study of Women's Health Across the NationArchives of internal medicine (1960), 2008
- Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and ProgestinJAMA, 2008
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Effect of Estrogen Plus Progestin on Stroke in Postmenopausal WomenJAMA, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Cardiovascular Disease Outcomes During 6.8 Years of Hormone TherapyJAMA, 2002